Cargando…
Co-Crystal Screening of Diclofenac
In the pharmaceutical industry, co-crystals are becoming increasingly valuable as crystalline solids that can offer altered/improved physical properties of an active pharmaceutical ingredient (API) without changing its chemical identity or biological activity. In order to identify new solid forms of...
Autores principales: | Aakeröy, Christer B., Grommet, Angela B., Desper, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857085/ https://www.ncbi.nlm.nih.gov/pubmed/24310599 http://dx.doi.org/10.3390/pharmaceutics3030601 |
Ejemplares similares
-
A systematic structural study of halogen bonding versus hydrogen bonding within competitive supramolecular systems
por: Aakeröy, Christer B., et al.
Publicado: (2015) -
The Impact of Halogen Substituents on the Synthesis and Structure of Co-Crystals of Pyridine Amides
por: Abeysekera, Amila M., et al.
Publicado: (2021) -
Structural Examination of Halogen-Bonded Co-Crystals of Tritopic Acceptors
por: Andree, Stefan N. L., et al.
Publicado: (2018) -
The Balance between Hydrogen Bonds, Halogen Bonds, and Chalcogen Bonds in the Crystal Structures of a Series of 1,3,4-Chalcogenadiazoles
por: De Silva, Viraj, et al.
Publicado: (2021) -
Diclofenac-proline nano-co-crystal development, characterization, in vitro dissolution and diffusion study
por: Nugrahani, Ilma, et al.
Publicado: (2020)